Health Care·Health Care Equipment·$45.0B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.15 | N/A | +5.19% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $2.15 | N/A | +5.19% |
| Revenue | N/A | N/A | N/A |
Tone: Confident
Management expressed confidence in their ongoing strategies and highlighted strong performance in key areas. They emphasized the importance of innovation in maintaining growth.
We are pleased with our performance this quarter, particularly in our core diagnostics business.
Our focus on innovation continues to drive growth and customer satisfaction.
IDEXX Labs reported a better-than-expected EPS, which contributed to a strong stock reaction, rising 9.8%. The positive surprise indicates strong operational performance, particularly in diagnostics. However, the lack of revenue data and guidance leaves some uncertainty for investors looking ahead.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
STRYKER CORP
Oct 31, 2022